https://www.selleckchem.com/products/SB939.html
8% on US but there was no enhancement on CT. All eight patients achieved no evidence of disease during mean follow-up of 33.0 months. RFA was tolerated by all patients; there were no major complications or procedure-related deaths. One patient experienced transient voice change during RFA. CONCLUSION. RFA can be considered to be an effective and safe alternative treatment method for recurrent tumor in the central compartment after hemithyroidectomy.OBJECTIVE. The objective of this study was to assess to the role of contrast-enhanced digit
Like
Comment
Share
